The University of Utah will manufacture certain materials derived from stem cells, as per the agreement. The University of Utah Clinical Regenerative Medicine and Tissue Engineering director Amit
Developed using the company’s PEGylation technology, PEG-SN38, a PEGylated conjugate of SN38 will provide therapeutic advantages over unmodified SN38 and current therapies. The Phase II study will investigate
PCI-32765 is an orally active, small molecule inhibitor of Bruton’s tyrosine kinase (Btk), an essential element of the B-cell antigen receptor (BCR) signaling pathway that causes tumor expansion.
As per the agreement, AstraZeneca will have access to injectable medicines used to treat infections and will make them available to patients in China. On completion of the
The 50/50 JV combines Microsoft’s platform expertise with GE Healthcare’s experience in clinical and administrative workflow solutions The JV will develop and market an open, interoperable technology platform
As part of the deal, Molecular Partners and Janssen Biotech will jointly develop DARPins and examine their use to address diseases where there is unmet needs for effective
Pycnogenol is an antioxidant plant extract from the bark of the French maritime pine tree. The study examined 53 Italian university students, aged 18-27, who were given 100
The Phase 3 program includes two randomized, double-blind, placebo-controlled studies, ULISES 007 and ULISES 008. The objective is to evaluate the efficacy and safety of daily 160 and
MelanPlus is believed to be a vitamin treatment for graying hair which addresses specific nutritional needs based on gender. According to the company, the new formulas contain Chinese
The facility, Unit-VI, has been granted approval for Cefotaxime sodium for injection, Ceftriaxone sodium for injection and Cefuroxime sodium for injection, indiainfoline.com reported. Following the approval, the company
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.